Cases 81 - 90 of 196
Otsuka Pharmaceutical Co., Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01965
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
CHIESI USA, INC. et al v. AUROBINDO PHARMA USA, INC. et al
as 2:2019cv18756
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD.
Plaintiff:
CHIESI USA, INC. and CHIESI FARMACEUTICI S.p.A.
Cause Of Action: 35 U.S.C. § 271
CHIESI USA, INC. et al v. AUROBINDO PHARMA USA, INC. et al
as 3:2019cv18756
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD.
Plaintiff:
CHIESI USA, INC. and CHIESI FARMACEUTICI S.P.A.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01862
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
as 1:2019cv01727
Counter Defendant:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant:
MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff:
Eden Biodesign, LLC.
Defendant:
Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01674
Plaintiff:
Allergan USA, Inc., Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company and others
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ACTELION PHARMACEUTICALS LTD v. AUROBINDO PHARMA USA INC. et al
as 3:2019cv15437
Defendant:
AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LIMITED
Plaintiff:
ACTELION PHARMACEUTICALS LTD
Cause Of Action: 15 U.S.C. § 1126
SENJU PHARMACEUTICAL CO., LTD et al v. AUROBINDO PHARMA USA INC. et al
as 3:2019cv13348
Defendant:
AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LIMITED
Plaintiff:
SENJU PHARMACEUTICAL CO., LTD, BAUSCH & LOMB INCORPORATED and BAUSCH & LOMB PHARMA HOLDINGS CORP.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
